|
Volumn 88, Issue 2, 2008, Pages 87-88
|
Amikacin
[No Author Info available]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMIKACIN;
AMINOGLYCOSIDE ANTIBIOTIC AGENT;
BETA LACTAM ANTIBIOTIC;
CAPREOMYCIN;
CYCLOSPORIN;
ETACRYNIC ACID;
FUROSEMIDE;
GENTAMICIN;
ISONIAZID;
KANAMYCIN;
LUKADIN;
MIKAVIR;
NOVAMIN;
STREPTOMYCIN;
SULFATE AMIGLYDE V;
TOBRAMYCIN;
VIOMYCIN;
ACINETOBACTER;
ANEMIA;
ANTIBACTERIAL ACTIVITY;
ANTIBIOTIC RESISTANCE;
ANTIBIOTIC SENSITIVITY;
APNEA;
AREA UNDER THE CURVE;
BACTERICIDAL ACTIVITY;
BACTERIUM ISOLATE;
BALANCE DISORDER;
COLONY FORMING UNIT;
DRUG CLEARANCE;
DRUG COST;
DRUG DISTRIBUTION;
DRUG EFFICACY;
DRUG HALF LIFE;
DRUG MECHANISM;
DRUG POTENCY;
DRUG POTENTIATION;
DRUG SAFETY;
DRUG TOLERABILITY;
ENDOCARDITIS;
ENTEROBACTER;
FEVER;
HEADACHE;
HEARING LOSS;
HUMAN;
HYPOTENSION;
MINIMUM INHIBITORY CONCENTRATION;
MYCOBACTERIUM TUBERCULOSIS;
NAUSEA;
NEPHROTOXICITY;
NEUROTOXICITY;
NONHUMAN;
OTOTOXICITY;
PARALYSIS;
PRIORITY JOURNAL;
PSEUDOMONAS;
RASH;
REVIEW;
STREPTOCOCCUS INFECTION;
TREMOR;
TUBERCULOSIS;
AMIKACIN;
ANIMALS;
ANTITUBERCULAR AGENTS;
HUMANS;
MICE;
TREATMENT OUTCOME;
TUBERCULOSIS;
|
EID: 43249122361
PISSN: 14729792
EISSN: None
Source Type: Journal
DOI: 10.1016/S1472-9792(08)70003-9 Document Type: Review |
Times cited : (6)
|
References (6)
|